Medikamentenvergleiche
Semaglutide vs. Ertugliflozin
Compare Semaglutide (Ozempic/Rybelsus) vs Ertugliflozin (Steglatro) for type 2 diabetes: weight loss, heart benefits, side effects, and which may be better.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
Patients with type 2 diabetes plus obesity or established cardiovascular/renal disease choosing between a GLP-1 agonist and an SGLT2 inhibitor.
Fazit
The preferred agent depends on individual goals such as substantial weight loss versus heart-failure or renal protection.
Alle Medikamentenvergleiche